electroCore to Participate at Upcoming Investor Conferences
Rhea-AI Summary
electroCore, Inc. (Nasdaq: ECOR) announced that CEO Dan Goldberger will participate in two upcoming conferences. The H.C. Wainwright 24th Annual Global Investment Conference is scheduled for September 14, 2022, from 12:30 to 1:00 PM EDT, featuring a fireside chat. The Ladenburg Thalmann 2022 Healthcare Conference will take place on September 29, 2022, from 3:30 to 3:55 PM EDT, where Goldberger will present. electroCore is focused on bioelectronic medicine, specializing in non-invasive vagus nerve stimulation therapies for conditions such as migraines and cluster headaches.
Positive
- None.
Negative
- None.
News Market Reaction – ECOR
On the day this news was published, ECOR declined 4.00%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
ROCKAWAY, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be participating at the H.C. Wainwright 24th Global Investment Conference and Ladenburg Thalmann 2022 Healthcare Conference.
H.C. Wainwright 24th Annual Global Investment Conference
Date: Wednesday, September 14, 2022
Time: 12:30 - 1:00 PM EDT
Event: Fireside Chat
Ladenburg Thalmann 2022 Healthcare Conference
Date: Thursday, September 29, 2022
Time: 3:30 - 3:55 PM EDT
Event: Presentation
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital
FAQ
When is electroCore's participation in the H.C. Wainwright conference?
What will Dan Goldberger present at the Ladenburg Thalmann Healthcare Conference?
What is the focus of electroCore's therapies?
What is the stock symbol for electroCore?
Where can I find more information about electroCore?
